Our recent work indicates that despite the decreased contractile muscle tissue in atrophic patients with COPD, the differences in ECM mRNA expression for collagen, fibronectin, tenascin C and biglycan between atrophic and nonatrophic patients with COPD are not translated at the protein level [11]. This evidence concerns the gene TNC and chronic obstructive pulmonary disease.